Effect of Mulligan Mobilization in Chronic Non-Spesific Low Back Pain
Unknown statusNot applicableNCT04297527
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Fifty five participants diagnosed with CNSLBP, will randomized into three groups. Group I (18 subjects) will receive 15 sessions of Conventional Physiotherapy program (CPP) 5 times per week, Group II (19 subjects) will receive 9 sessions of SNAGs, and Group III will receive CPP plus SNAGs. Outcome measures are pain, ROM, spinal mobility, fear avoidance behaviour and function. Measurements will record before, after and 6 month after the end of the treatment.
Study details
- Official title
- Efficacy of Mulligan Mobilization Technique in Chronic Non-Spesific Low Back Pain
- Conditions
- Interventions
- Procedure: Conventional Physiotherapy
- Procedure: Mulligan Mobilization
- Sponsor
- Pamukkale University
- Start date
- 2017-06-14
- Primary completion
- 2020-06
- Sex
- Female
- Age range
- from 20 Years to 50 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * low back pain for at least 3 months * intensity of pain ranges from 3 to 6 according to VAS Exclusion Criteria: * undergoing surgical operation in the lumbar region or having a surgical indication having an exercise therapy and / or physical therapy in the last 1 year * a history of trauma involving lumbar region and systemic and inflammatory disease targeting this region * corticosteroids consumption for a long time * being pregnant.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04297527